Get Live Data
Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Share Prices
  3. Tristel Share Price
  4. Tristel Share Regulatory News
  5. Director/PDMR Shareholding

Pin to quick picksTristel Regulatory News (TSTL)

Tristel Information

Share Price Information for Tristel (TSTL)

Share Price is delayed by 15 minutes
Get Live Data
387.50    -5.00 (-1.27%)
Bid:
380.00
Ask:
395.00
Spread: 15.00 (3.947%)
Market Cap: £185.99m
TSTL Live PriceLast checked at - London Stock Exchange

Intraday Tristel Share Chart

Director/PDMR Shareholding

28 May 2008 11:32

RNS Number : 3930V
Tristel PLC
28 May 2008
Β 

ο»Ώ

Tristel plc

("Tristel" orΒ theΒ "Company")

Director/PDMR Shareholding

The Board of Tristel plc, the AIM listed provider of infection and contamination control products, has been informed that onΒ 27Β May 2008,Β Bruce Green,Β a director of the Company,Β purchasedΒ 5,000Β ordinary shares of 1p each ("Ordinary Shares") in the Company at a price of 50p per share.

Following this transaction, MrΒ GreenΒ hasΒ an interest inΒ 914,016Β Ordinary Shares,Β representing approximatelyΒ 3.4Β per cent. of the issued share capital of the Company.

Enquiries:

Tristel plc

Paul Swinney, Chief Executive Tel: 01638 721 500

Daniel Stewart & Company plc

Graham Webster/Tessa Smith Tel: 020 7776 6550

Parkgreen Communications Limited

Paul McManus Tel: 020 7479 7933

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
RDSFGGZKGRGGRZM
12345678910
Date   Source Headline
12th Oct 20237:00 amRNSAdditional Investor Presentation
10th Oct 20234:45 pmRNSExercise of Share Options and Total Voting Rights
2nd Oct 202311:50 amRNSHolding(s) in Company
28th Sep 20232:00 pmRNSExercise of Share Options and Total Voting Rights
26th Sep 20232:40 pmRNSHolding(s) in Company
25th Sep 20238:40 amRNSHolding(s) in Company
22nd Sep 20233:40 pmRNSHolding(s) in Company
12th Sep 20237:00 amRNSNotice of Results
4th Sep 20237:00 amRNSHealth Canada regulatory approval submission
31st Jul 20238:05 amRNSHolding(s) in Company
28th Jul 20238:28 amRNSDirector/PDMR Shareholding
25th Jul 20237:00 amRNSTrading update
12th Jul 20237:00 amRNSShareholder Open Day and Notice of Trading Update
10th Jul 20237:00 amRNSExercise of Share Options and Total Voting Rights
26th Jun 20237:00 amRNSDirector/PDMR Shareholding
22nd Jun 20234:01 pmRNSHolding(s) in Company
16th Jun 20237:00 amRNSExercise of Share Options and Total Voting Rights
14th Jun 20234:10 pmRNSHolding(s) in Company
6th Jun 20235:00 pmRNSExercise of Share Options and Total Voting Rights
5th Jun 202310:00 amRNSAnalyst and Investor presentation
5th Jun 20237:00 amRNSFDA De Novo approval
28th Mar 202311:30 amRNSIssue of Equity
27th Mar 20237:00 amRNSSuccessful submission of additional data to US FDA
14th Mar 20232:05 pmRNSSecond Price Monitoring Extn
14th Mar 20232:00 pmRNSPrice Monitoring Extension
14th Mar 20239:30 amRNSIssue of Equity
22nd Feb 20234:30 pmRNSIssue of Equity
20th Feb 20237:00 amRNSHalf-year Report
30th Jan 20237:00 amRNSNotice of Results and Investor presentation
14th Dec 202211:00 amRNSResult of AGM - Replacement
13th Dec 20227:00 amRNSIssue of Equity
12th Dec 202211:26 amRNSResult of AGM
12th Dec 20227:00 amRNSAGM Statement
2nd Nov 20221:50 pmRNSHolding(s) in Company
25th Oct 20227:00 amRNSAudited Preliminary Results
6th Oct 20229:15 amRNSIssue of Equity
4th Oct 202212:00 pmRNSAppointment of new Company Secretary
4th Oct 20227:00 amRNSNotice of Results & Investor Presentation
29th Sep 20221:00 pmRNSNorth America update
30th Aug 20227:00 amRNSHolding(s) in Company
22nd Jul 20221:05 pmRNSDirector/PDMR Shareholding
21st Jul 202210:15 amRNSHolding(s) in Company
18th Jul 20224:41 pmRNSSecond Price Monitoring Extn
18th Jul 20224:35 pmRNSPrice Monitoring Extension
18th Jul 20227:00 amRNSTrading update and special dividend
30th Jun 20227:00 amRNSDe Novo FDA submission for Tristel Duo ULT
20th Jun 202210:00 amRNSShareholder Open Day & Notice of Trading update
7th Jun 20221:15 pmRNSHolding(s) in Company
4th May 20227:00 amRNSInvestor Presentation
3rd May 202212:30 pmRNSHolding(s) in Company
12345678910

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Recently viewed
MWY
Mid Wynd International Investment Trust
LSE
-0.26%
REDD
REDD.L
LSE
0.00%
ABC
ABC.L
LSE
0.00%
FAS
Fidelity Asian Values
LSE
-0.70%
HSP
Hargreaves Serv
LSE
0.25%
Trending
PREM
Premier African Minerals
LSE
-2.78%
GST
GSTechnologies
LSE
4.04%
CPI
Capita
LSE
3.62%
QED
Quadrise
LSE
1.01%
KOD
Kodal Minerals
LSE
0.00%